JANX Covered Call Strategy

JANX (Janux Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors. Currently, Janux has several promising TRACTr product candidates in their early preclinical or discovery stages, which are engineered to target specific antigens such as prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. In addition to its TRACTr pipeline, the company is also developing a Tumor Activated Immunomodulator (TRACIr) — a costimulatory bispecific candidate designed to enhance T cell anti-tumor activity by engaging with programmed death-ligand 1 and CD28. Furthermore, a specific focus for their EGFR-TRACTr program is addressing epidermal growth factor receptor, a target prevalent in many cancer types and already a focus of numerous approved monoclonal antibody treatments. Janux Therapeutics, Inc. was founded in 2017 and is headquartered in La Jolla, California.

JANX (Janux Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $695.7M, a beta of 2.39 versus the broader market, a 52-week range of 11.155-35.34, average daily share volume of 889K, a public-listing history dating back to 2021, approximately 113 full-time employees. These structural characteristics shape how JANX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.39 indicates JANX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a covered call on JANX?

A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.

JANX snapshot

As of November 13, 2026, spot at $11.44, ATM IV 94.20%, IV rank 32.62%, expected move 27.01%. The covered call on JANX below is built from the November 13, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this covered call structure on JANX specifically: JANX IV at 94.20% is mid-range versus its 1-year history, so the credit collected on a JANX covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 27.01% (roughly $3.09 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated JANX expiries trade a higher absolute premium for lower per-day decay. Position sizing on JANX should anchor to the underlying notional of $11.44 per share and to the trader's directional view on JANX stock.

JANX covered call setup

The JANX covered call below is built from the November 13, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With JANX at $11.44 on that close, the first option leg uses a $12.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed JANX chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 JANX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 100 sharesStock$11.44long
Sell 1Call$12.50$0.75

JANX covered call risk and reward

Net Premium / Debit
-$1,069.00
Max Profit (per contract)
$181.00
Max Loss (per contract)
-$1,068.00
Breakeven(s)
$10.69
Risk / Reward Ratio
0.169

Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.

JANX covered call payoff curve

Modeled P&L at expiration across a range of underlying prices for the covered call on JANX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

JANX covered call profit and loss curve at expiration with breakevens and current spot markedJANX covered call payoff at expiration-$1000-$800-$600-$400-$200$0$5$10$15$20Underlying Price ($)P&L at Expiration ($)BE $10.69Spot $11.44
P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.
Underlying Price% From SpotP&L at Expiration
$0.01-99.9%-$1,068.00
$2.54-77.8%-$815.17
$5.07-55.7%-$562.33
$7.60-33.6%-$309.50
$10.12-11.5%-$56.66
$12.65+10.6%+$181.00
$15.18+32.7%+$181.00
$17.71+54.8%+$181.00
$20.24+76.9%+$181.00
$22.77+99.0%+$181.00

When traders use covered call on JANX

Covered calls on JANX are an income strategy run on existing JANX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.

JANX thesis for this covered call

The market-implied 1-standard-deviation range for JANX extends from approximately $8.35 on the downside to $14.53 on the upside. A JANX covered call collects premium on an existing long JANX position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether JANX will breach that level within the expiration window. Current JANX IV rank near 32.62% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on JANX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, JANX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to JANX-specific events.

JANX covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. JANX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move JANX alongside the broader basket even when JANX-specific fundamentals are unchanged. Short-premium structures like a covered call on JANX carry tail risk when realized volatility exceeds the implied move; review historical JANX earnings reactions and macro stress periods before sizing. Always rebuild the position from current JANX chain quotes before placing a trade.

Frequently asked questions

What is a covered call on JANX?
A covered call on JANX is the covered call strategy applied to JANX (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With JANX stock at $11.44 on the November 13, 2026 close, the strikes shown on this page are snapped to the nearest listed JANX chain strike and the premiums come straight from that session's bid/ask midpoint.
How are JANX covered call max profit and max loss calculated?
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the JANX covered call priced from the November 13, 2026 end-of-day chain at a 30-day expiry (ATM IV 94.20%), the computed maximum profit is $181.00 per contract and the computed maximum loss is -$1,068.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a JANX covered call?
The breakeven for the JANX covered call priced on this page is roughly $10.69 at expiration, derived from the November 13, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The JANX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 27.01%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a covered call on JANX?
Covered calls on JANX are an income strategy run on existing JANX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
How does current JANX implied volatility affect this covered call?
JANX ATM IV is at 94.20% with IV rank near 32.62%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related JANX analysis